Decision Tangible Asset Value from 2010 to 2026

DECN Stock  USD 0.0001  0.00  0.000003%   
Decision Diagnostics Tangible Asset Value yearly trend continues to be very stable with very little volatility. Tangible Asset Value is likely to drop to 0.00. Tangible Asset Value is the total value of a company's physical, tangible assets, excluding intangible assets like patents and trademarks. View All Fundamentals
 
Tangible Asset Value  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Decision Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Decision Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 32.9 M, Selling General Administrative of 2.6 M or Total Revenue of 1.7 M, as well as many indicators such as Price To Sales Ratio of 2.65, Dividend Yield of 0.068 or PTB Ratio of 7.9. Decision financial statements analysis is a perfect complement when working with Decision Diagnostics Valuation or Volatility modules.
  
Build AI portfolio with Decision Stock
Check out the analysis of Decision Diagnostics Correlation against competitors.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Check out the analysis of Decision Diagnostics Correlation against competitors.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Health Care Technology sector continue expanding? Could Decision diversify its offerings? Factors like these will boost the valuation of Decision Diagnostics. Projected growth potential of Decision fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Decision Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
Understanding Decision Diagnostics requires distinguishing between market price and book value, where the latter reflects Decision's accounting equity. The concept of intrinsic value—what Decision Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Decision Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Decision Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Decision Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Decision Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.